Do ketone supplements regulate islet hormone secretion?

Ketone supplementation has been gaining interest in improving health and treating some diseases, such as diabetes. However, the mechanism of action of how these ketone supplements work is not fully understood. In a recent paper, Banerjee et al. (2024) showed that physiological concentrations of βHB can affect hormone secretion and signalling within pancreatic islets. They showed that acute treatment with βHB increases insulin secretion and decreases glucagon secretion at physiological glucose concentrations. Their studies also suggest chronic βHB treatment may protect human islet cells from cytokine-induced cell death. Although more work is needed, it is possible that physiological concentrations of βHB may influence hormone secretion and signalling within islets.

• Publication year

  2024

• Venue

  Endocrinology

• Publication date

  2024-10-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/endocr/bqae133PMID 39363149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-Hydroxybutyrate Promotes Basal Insulin Secretion While Decreasing Glucagon Secretion in Mouse and Human Islets

  2024cited by this paper
• Ketone Ester Administration Improves Glycemia in Obese Mice.

  2023cited by this paper
• The effect of acute and 14-day exogenous ketone supplementation on glycaemic control in adults with type 2 diabetes: two randomized controlled trials.

  2023cited by this paper
• The Effect of Novel Exogenous Ketone Supplements on Blood Beta-Hydroxybutyrate and Glucose

  2022cited by this paper
• Ketone bodies: from enemy to friend and guardian angel

  2021cited by this paper
• Differences between Human and Rodent Pancreatic Islets

  2011cited by this paper
• Acetoacetate and beta-hydroxybutyrate in combination with other metabolites release insulin from INS-1 cells and provide clues about pathways in insulin secretion.

  2008cited by this paper
• Chronic exposure to beta-hydroxybutyrate inhibits glucose-induced insulin release from pancreatic islets by decreasing NADH contents.

  2005cited by this paper

• No citing papers are available for this paper.